Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 4 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Zollinger-Ellison Syndrome 1Unspecified Adult Solid Tumor, Protocol Specific 1Somatostatinoma 1Paraganglioma 1Insulinoma 1Glucagonoma 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoid Tumor 1Adenoma, Islet Cell 1Acromegaly 1

Interventions

Everolimus 3pasireotide 2veliparib 1gallium Ga 68 dotatate 1Temozolomide 1Sorafenib 1Rose Bengal 1Radiotherapy 1Radiation 1Proton Therapy 1Octreotide 1Ga(III)-DOTATOC 1Dacarbazine 1Capecitabine 1Bortezomib 1Biological Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinoid Tumor × Octreotide × Clear all
NCT03057509 2019-06-21

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Massachusetts General Hospital

Phase 1 Withdrawn
Endocrine

Carcinoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡